Your Article Summary
See Latest ArticlesORENCIA (abatacept) Demonstrates Consistent Safety and Effectiveness Over 7 Years
Bristol Myers-Squibb Company, 06/18/09
The first, a long-term extension study, analysed ORENCIA's safety and efficacy profile over 7 years of treatment in rheumatoid arthritis patients who have had an inadequate response to methotrexate.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09
New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer
Genentech, 12/15/09
GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
GlaxoSmithKline, 12/15/09